Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gulfiya Midhatovna Teletaeva"'
Autor:
Gulfiya Midhatovna Teletaeva, Tatyana Semiglazova, Igor Berlev, Anna Semenova, Svetlana Protsenko, Adel Urmancheeva, Dariya Ulrikh, Evgenii Levchenko
Publikováno v:
Problems in oncology. 66:667-672
Objective: to summarize the experience of treatment patients with resistant forms of gestational trophoblastic neoplasia (GTN). Materials and methods: results of treatment of 15 patients with resistant forms of GTN treated in the N.N. Petrov Research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77447d09b6e838271ff84bd2683e81d4
https://doi.org/10.37469/0507-3758-2020-66-6-667-672
https://doi.org/10.37469/0507-3758-2020-66-6-667-672
Autor:
T. Yu. Semiglazova, Gulfiya Midhatovna Teletaeva, Vladislav Semiglazov, D. O. Yurlov, Irina Alexandrovna Baldueva, Dilorom Latipova, Svetlana Protsenko, Z. S. Kotova, Alexey Viktorovich Novik, Anna Semenova
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 172-175 (2018)
The aim of this study is to analyse the efficacy of efferent therapy (hemosorption) as part of drug treatment in patients with metastatic colorectal cancer (mCRC) based on the use of standard first-line chemotherapy combined with the bevacizumab bios
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83977ae8a36b1a632b44013cda438ded
https://www.med-sovet.pro/jour/article/view/2554
https://www.med-sovet.pro/jour/article/view/2554
Autor:
Irina Baldueva, Svetlana Protsenko, Gulfiya Midhatovna Teletaeva, Yekaterina Yaremenko, Aleksey Novik, Dilorom Latipova, Tatyana Semiglazova, V. Rubinchik, Anna Semenova, Yekaterina Anokhina, Ani Oganesyan
Publikováno v:
Problems in oncology. 64:388-393
Ipilimumab (IPI) provides a ten-year overall survival in almost 20 % of selected patients participated in several phase II-III trials. However, the expanded access program (EAP) looks more like routine practice than like clinical trials& This is why
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea7862d66600315c5616d5c7fadf1ee6
https://doi.org/10.37469/0507-3758-2018-64-3-388-393
https://doi.org/10.37469/0507-3758-2018-64-3-388-393
Autor:
Boris Kasparov, Vladislav Semiglazov, L.V. Filatova, R.V. Donskikh, Yu.V. Alekseeva Alekseeva, S.V. Kondratiev, A. Belyaev, S.M. Sharashenidze, N. A. Brish, Gulfiya Midhatovna Teletaeva, Tkachenko Ev, Svetlana Protsenko, T.Y. Semiglazova, M. I. Sluzhev, D.K. Latipova
Publikováno v:
Annals of Oncology. 32:S576
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3414daedb0777f259a67708233e623e5
https://doi.org/10.1016/j.annonc.2021.08.1016
https://doi.org/10.1016/j.annonc.2021.08.1016
Autor:
Gulfiya Midhatovna Teletaeva, Filatova Lv, Dilorom Latipova, Veronika Klimenko, Irina Baldueva, Mikhail Osipov, Yuriy Komarov, Z. S. Kotova, Natalya Buevich, Anna Semenova, Margarita Motalkina, Aleksandr Stukov, Svetlana Protsenko, Yekaterina Anokhina, Tatyana Semiglazova, Yevgeniya Kharchenko, Aleksey Novik, Sergey Alekseev
Publikováno v:
Problems in oncology. 63:346-352
In 1947 for the first time in the USSR in the Leningrad Institute of Oncology L.F. Larionov and and V.G. Nemets have developed and clinically tested the first domestic cytostatic embihin. Since that time more than 150 different anti-cancer agents and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bb6952bfc8bc0bbf3267fd6ee91e190
https://doi.org/10.37469/0507-3758-2017-63-2-346-352
https://doi.org/10.37469/0507-3758-2017-63-2-346-352
Autor:
Anna Semenova, N. Avdokina, Anna Danilova, Yuriy Komarov, Natalya Yemelyanova, Aleksey Belyaev, Mark Gelfond, Aleksey Novik, Irina Baldueva, Aleksandr Shcherbakov, Tatyana Nekhaeva, Olga Galiullina, Nino Pipia, Yekaterina Anokhina, Dilorom Latipova, Svetlana Protsenko, Tatyana Semiglazova, Gulfiya Midhatovna Teletaeva, Z. S. Kotova
Publikováno v:
Problems in oncology. 63:336-345
There are described the results of clinical and immunological efficacy assessment of active specific immunotherapy with autologous immature dendritic cells (DC) combined with photodynamic therapy (PDT) and cyclophosphamide (C) in disseminated melanom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::331f71f5984a7a841b4373c8de5c51e5
https://doi.org/10.37469/0507-3758-2017-63-2-336-345
https://doi.org/10.37469/0507-3758-2017-63-2-336-345
Autor:
Dmitrii Viktorovich Girdyuk, Irina Alexandrovna Baldueva, Dilorom Khamidovna Latipova, Gulfiya Midhatovna Teletaeva, Tatyana Nekhaeva, Aleksei Viktorovich Novik, Natalia Viktorovna Emelyanova, Anna Semenova, Svetlana Protsenko
Publikováno v:
Journal of Clinical Oncology. 39:2539-2539
2539 Background: The immune system has well-known relation to tumor progression. Numerous immune-related parameters exist, but only a minor part could be used as biomarkers, especially dynamic ones. We trained a progression prediction model based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f147b3314ecbdc10fc50b2904e04246
https://doi.org/10.1200/jco.2021.39.15_suppl.2539
https://doi.org/10.1200/jco.2021.39.15_suppl.2539
Autor:
Dilorom Khamidovna Latipova, Svetlana Protsenko, Irina Alexandrovna Baldueva, Natalya Shendaleva, Anton Zozulya, Anna Semenova, Gulfiya Midhatovna Teletaeva, Tatyana Nekhaeva, Aleksei Viktorovich Novik, Tatiana Semiglazova
Publikováno v:
Journal of Clinical Oncology. 39:e23534-e23534
e23534 Background: Immunomodulators are used in the management of patients with soft tissue sarcoma, (STS). However, the precise mechanism behind their benefits in anticancer therapy effects have yet to be determined. We assessed the impact of the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cffc010b2de262072202b1768c98a7c4
https://doi.org/10.1200/jco.2021.39.15_suppl.e23534
https://doi.org/10.1200/jco.2021.39.15_suppl.e23534
Autor:
V F Semiglazov, P. Krivorotko, Gulfiya Midhatovna Teletaeva, Paltuev Rm, R V Donskikh, Tkachenko Ev, V. A. Klyuge, T Yu Semiglazova, G.A. Dashyan, Vladislav Semiglazov
Publikováno v:
Современная онкология, Vol 18, Iss 2, Pp 27-33 (2016)
Since 1990-s the efficiency of treatment of patients with metastatic/advanced breast cancer (MBC) was started to evaluate not only by overall survival but also by quality of life which is characterized by physical, social, mental and emotional condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed0f15608368d0042a5612767e31f07
https://modernonco.orscience.ru/1815-1434/article/viewFile/27066/pdf
https://modernonco.orscience.ru/1815-1434/article/viewFile/27066/pdf
Autor:
N. A. Brish, Aleksey Belyaev, Boris Kasparov, Gulfiya Midhatovna Teletaeva, Vladislav Semiglazov, Elena V. Tkachenko, Svetlana Protsenko, Filatova Lv, Tatiana Semiglazova, Dilorom Latipova, Iuliia Vladimirovna Alekseeva, Veronika Klimenko
Publikováno v:
Journal of Clinical Oncology. 38:e16041-e16041
e16041 Background: The concomitant pathology, cancer and geriatric status affect the organism of a sick elderly person. In routine clinical practice elderly patients require comprehensive geriatric assessment (CGO). Despite many treatment strategies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54e16283a36669bf7965736365dc1d73
https://doi.org/10.1200/jco.2020.38.15_suppl.e16041
https://doi.org/10.1200/jco.2020.38.15_suppl.e16041